SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-24-005060
Filing Date
2024-04-26
Accepted
2024-04-26 08:00:38
Documents
7
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A zivo_def14a.htm DEF 14A 468231
2 zivo_def14aimg10.jpg GRAPHIC 30037
3 zivo_def14aimg16.jpg GRAPHIC 1235
4 zivo_def14aimg17.jpg GRAPHIC 1116
5 zivo_def14aimg18.jpg GRAPHIC 1072
6 zivo_def14aimg19.jpg GRAPHIC 1360
7 zivo_def14aimg9.jpg GRAPHIC 28363
  Complete submission text file 0001654954-24-005060.txt   557342
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40449 | Film No.: 24878863
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)